• OPEN AN ACCOUNT
Indian Indices
Sensex
77,966.35 -187.90
( -0.24%)
Global Indices
Nasdaq
53,805.64 -191.34
(-0.35%)
Dow Jones
7,747.95 -26.16
(-0.34%)
Hang Seng
67,546.56 576.34
(0.86%)
Nikkei 225
10,849.18 -13.32
(-0.12%)
Forex
USD-INR
95.28 0.13
(0.14%)
EUR-INR
110.05 0.08
(0.07%)
GBP-INR
128.64 0.30
(0.23%)
JPY-INR
0.60 0.00
(-0.45%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
193.0629905
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
52.63
14963.78
EPS(TTM)
Face Value()
Div & Yield %
27.18
1
0.53
 

urja global ltd
Ramco Systems consolidated net profit rises 371.75% in the March 2026 quarter
May 22,2026
Net profit of Ramco Systems rose 371.75% to Rs 25.05 crore in the quarter ended March 2026 as against Rs 5.31 crore during the previous quarter ended March 2025. Sales rose 19.39% to Rs 185.36 crore in the quarter ended March 2026 as against Rs 155.26 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 41.84 crore in the year ended March 2026 as against net loss of Rs 34.25 crore during the previous year ended March 2025. Sales rose 18.54% to Rs 700.95 crore in the year ended March 2026 as against Rs 591.34 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales185.36155.26 19 700.95591.34 19
OPM %24.3326.74 -22.6112.79 -
PBDT45.1942.91 5 161.8176.31 112
PBT22.107.42 198 70.45-26.46 LP
NP25.055.31 372 41.84-34.25 LP